Skip to content
healthcare.dev
Get a free key

FLUZONE TRIVALENT NORTHERN HEMISPHERE

NDC 49281-426, INFLUENZA A VIRUS A/Switzerland/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Michigan/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/Tokyo/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED), injection, suspension, from Sanofi Vaccines US Inc..

Product NDC
49281-426
Status
Listed
Labeler
Sanofi Vaccines US Inc.
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA103914
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49281-426 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug/.5mg
  • INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug/.5mg
  • INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug/.5mg
Package NDCNDC-11Package
49281-426-504928104265010 SYRINGE, GLASS in 1 PACKAGE (49281-426-50) / .5 mg in 1 SYRINGE, GLASS (49281-426-88)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 49281-426 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49281-426 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49281-426. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.